Comparing two creams for patchy hair loss
Treatments studied
Part of Skin clinical trials.
This study compares two treatments for patchy hair loss on the scalp: a vitamin D-like cream (calcipotriol) and steroid injections (intralesional steroids). It aims to see which is more effective at regrowing hair in adults with less than half of the scalp affected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 50 years old.
- You have patchy hair loss on your scalp (not all over), and it covers less than half of your scalp.
- You have not used any topical or systemic (pill or injection) treatment for hair loss in the last 3 months.
- You are willing to give written consent to participate.
- You do not have other autoimmune diseases (like lupus or rheumatoid arthritis) or serious health conditions.
- You are not pregnant or breastfeeding, and you are not allergic to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
This study tests whether a methotrexate lotion or minoxidil lotion is better at regrowing hair in people with patchy hair loss on the scalp. You will use one of the treatments for a period of time, and the doctors will check your progress.
This trial compares a cholesterol-lowering cream (simvastatin) with a standard steroid cream to treat patchy hair loss from alopecia areata. It aims to find a gentler, more effective way to help hair regrow on the scalp.
This study uses a special UV light to look at your scalp in a new way. It may help doctors better understand and monitor alopecia areata (a condition that causes patchy hair loss). Participation involves only imaging, no drugs or invasive procedures.
This study tests a new cream or lotion for people with patchy hair loss (alopecia areata) that covers less than half of the scalp. It aims to see if the treatment helps hair grow back in those patches.
This Phase 2 trial tests dupilumab (an injection medicine) to regrow hair in people with alopecia areata, a condition where the immune system attacks hair follicles. It may help by reducing the immune-related inflammation linked to hair loss.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.